Efficacy of high sensitivity c- reactive protein, Lipoprotein A and Troponin I levels in Predicting Cardiovascular Disease Severity on Coronary Angiogram- A Prospective Study
Research Square
2024
Metric Options: CountsSelecting the 1-year or 3-year option will change the metrics count to percentiles, illustrating how an article or review compares to other articles or reviews within the selected time period in the same journal. Selecting the 1-year option compares the metrics against other articles/reviews that were also published in the same calendar year. Selecting the 3-year option compares the metrics against other articles/reviews that were also published in the same calendar year plus the two years prior.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Article Description
Background: Cardiovascular diseases (CVDs) continue to be the primary cause of death globally, significantly contributing to health deterioration and increased healthcare expenses. Annually, CVDs are responsible for more deaths than any other disease, causing approximately 17.9 million deaths, which equates to around 31% of global mortality. This study investigated the efficacy of high sensitivity c- reactive protein (hs-CRP), Lipoprotein A levels (Lipo A), and Troponin I (Trop I) levels in predicting CVD severity on coronary angiogram Materials and Methods: This prospective observational study included 211 patients aged 18 years and above, with a diagnosis of acute coronary syndrome (ACS), visiting the Department of Cardiology. Detailed history was recorded, and laboratory investigations included hs-CRP, Lipo A, Trop I, and Lipid Profile, and all the patients were subjected to coronary angiography. Coronary angiogram was studied and severity of CVD was noted, based on SYNTAX I and II. Results: The mean age of study patients was 62.82±10.17 years, with age ranging from 34 to 89 years, and majority being male (70.1%). 78.7% of patients were hypertensive and 71.6% were diabetic. Most common signs and symptom were chest pain (96.2%) and dyspnoea (87.2%). The higher levels of mean hs-CRP, Lipo A, Trop I, and LDL were significantly associated with severity of CVD on coronary angiogram (p<0.001). Conclusion: Higher levels of hs- CRP, Lipo A and Trop I can be a reliable predictor of severity of CVD on coronary angiograma.
Bibliographic Details
Springer Science and Business Media LLC
Provide Feedback
Have ideas for a new metric? Would you like to see something else here?Let us know